EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of point‐of‐care maternal viral load testing at delivery on vertical HIV transmission risk assessment and neonatal prophylaxis: a cluster randomized trial

Anange Fred Lwilla iD, Kira Elsbernd, Siriel Boniface, Raphael Edom, Arlete Mahumane, Bindiya Meggi, W Chris Buck iD, Joaquim Lequechane, Kassia Pereira iD, Nhamo Chiwerengo, Falume Chale, Chishamiso Mudenyanga und 9 weitere

Journal of the International AIDS Society · 2025

DOI: 10.1002/jia2.70021 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the International AIDS Society, 2025. Verfasst von Anange Fred Lwilla und 20 weiteren Autor:innen. Beteiligte Einrichtung: Mbeya Medical Research Center, National Institute for Medical Research, (NIMR), Mbeya, Tanzania. Hauptthemen laut MEDLINE: HIV Infections, Infectious Disease Transmission, Vertical, Viral Load, Point-of-Care Testing. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership, UNITAID, the German Center for Infection Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite global reductions in vertical HIV transmission (VHT), 120,000 children newly acquired HIV in 2023. High maternal viral load (VL) is a major risk factor for VHT. We estimated the impact of point‐of‐care (PoC) maternal VL testing at delivery in profiling the risk of VHT and its impact on appropriate postnatal prophylaxis for infants born to women living with HIV (WLWH).

Methods

The cluster‐randomized LIFE (Long term Impact on inFant hEalth) study was conducted at 28 health facilities in Tanzania and Mozambique from 2019 to 2021. At delivery, the intervention arm applied PoC maternal VL plus clinical criteria for VHT risk assessment, while the control arm used clinical criteria only. In Tanzania, both arms provided ePNP based on maternal risk factors, while Mozambique provided ePNP universally. We used mixed effects logistic regression to estimate the intervention effect on the proportion of infants at high risk (Tanzania and Mozambique) and infants at high risk receiving ePNP (Tanzania only).

Results

A total of 6467 WLWH were enrolled: 66.3% were diagnosed before the third trimester, 99% were on antiretroviral therapy and 78% were virally suppressed at delivery. Of 6564 newborns of WLWH included, 774 (11.7%) were identified to be at a high risk: 629 (19.3%) versus 145 (4.4%) in intervention and control arms, respectively; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsInfectious Disease Transmission, VerticalViral LoadPoint-of-Care TestingPregnancy Complications, InfectiousPoint-of-Care SystemsHumansFemalePregnancyInfant, NewbornTanzaniaMozambiqueAdultRisk AssessmentAnti-HIV AgentsYoung AdultInfant

Stichwörter der Autor:innen

HIV acquisitionsinfantnewbornpoint‐of‐care systemsrisk assessmentviral load

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Mbeya Medical Research Center, National Institute for Medical Research, (NIMR), Mbeya, Tanzania.
  • Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
  • Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Pettenkofer School of Public Health, Munich, Germany.
  • Instituto Nacional de Saúde (INS), Maputo, Mozambique.
  • David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Clinton Health Access Initiative (CHAI), Maputo, Mozambique.

ORCID-Profile: Anange Fred Lwilla, W Chris Buck, Kassia Pereira

Förderung

  • European and Developing Countries Clinical Trials Partnership
  • UNITAID
  • the German Center for Infection Research
  • Deutsches Zentrum für Infektionsforschung

Zitieren

APA

Lwilla, A. F., Elsbernd, K., Boniface, S., Edom, R., Mahumane, A., Meggi, B., Buck, W. C., Lequechane, J., Pereira, K., Chiwerengo, N., Chale, F., Mudenyanga, C., Mutsaka, D., Mueller, M., Ntinginya, N. E., Taveira, N., Hoelscher, M., Jani, I., Kroidl, A., …, & and the LIFE Study Consortium (2025). Impact of point‐of‐care maternal viral load testing at delivery on vertical HIV transmission risk assessment and neonatal prophylaxis: a cluster randomized trial. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.70021

Vancouver

Lwilla AF, Elsbernd K, Boniface S, Edom R, Mahumane A, Meggi B, et al. Impact of point‐of‐care maternal viral load testing at delivery on vertical HIV transmission risk assessment and neonatal prophylaxis: a cluster randomized trial. Journal of the International AIDS Society. 2025. doi:10.1002/jia2.70021

BibTeX
@article{Lwilla2025,
  author = {Lwilla, Anange Fred and Elsbernd, Kira and Boniface, Siriel and Edom, Raphael and Mahumane, Arlete and Meggi, Bindiya and Buck, W Chris and Lequechane, Joaquim and Pereira, Kassia and Chiwerengo, Nhamo and Chale, Falume and Mudenyanga, Chishamiso and Mutsaka, Dadirayi and Mueller, Marianna and Ntinginya, Nyanda E and Taveira, Nuno and Hoelscher, Michael and Jani, Ilesh and Kroidl, Arne and Sabi, Issa and and the LIFE Study Consortium, and the LIFE Study Consortium},
  title = {Impact of point‐of‐care maternal viral load testing at delivery on vertical HIV transmission risk assessment and neonatal prophylaxis: a cluster randomized trial},
  journal = {Journal of the International AIDS Society},
  year = {2025},
  doi = {10.1002/jia2.70021}
}
Kostenlos starten →